Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Transmedics Group Inc (TMDX)

13.25   0.22 (1.69%) 10-24 14:02
Open: 13.445 Pre. Close: 13.03
High: 13.45 Low: 12.99
Volume: 37,691 Market Cap: 360M
TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. The company is headquartered in Andover, Massachusetts and currently employs 92 full-time employees. The company is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The firm has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Lung INSPIRE Trial, OCS Lung Expand Trial, OCs Heart EXPAND and PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. The company is also focused on developing additional OCS products for kidney transplantation.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.47 - 13.524 13.524 - 13.58
Low: 12.859 - 12.914 12.914 - 12.971
Close: 13.158 - 13.255 13.255 - 13.356

Technical analysis

as of: 2020-10-23 4:49:40 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 17.05     One year: 18.41
Support: Support1: 12.71    Support2: 10.57
Resistance: Resistance1: 14.59    Resistance2: 15.76
Pivot: 13.43
Moving Average: MA(5): 13.09     MA(20): 13.57
MA(100): 16.32     MA(250): 16.64
MACD: MACD(12,26): -0.67     Signal(9): -0.75
Stochastic oscillator: %K(14,3): 20.16     %D(3): 17.62
RSI: RSI(14): 37.32
52-week: High: 20.99  Low: 10.10  Change(%): -27.6
Average Vol(K): 3-Month: 18705  10-Days: 7742

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TMDX has closed above bottom band by 39.5%. Bollinger Bands are 31.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 21 Oct 2020
TransMedics to Report Third Quarter 2020 Financial Results on November 4, 2020 - Yahoo Finance

Wed, 30 Sep 2020
Think You Need A Good Stock? Look At This TransMedics Group, Inc. (NASDAQ:TMDX) Analysis - Stocks Register

Wed, 30 Sep 2020
TransMedics Group Inc. (TMDX) volume hits 1.76 million: A New Opening for Investors - News Daemon

Tue, 29 Sep 2020
Do Analysts Agree on TransMedics Group Inc (TMDX) Stock's Target Price? - InvestorsObserver

Tue, 29 Sep 2020
Boiling and ready to burst as TransMedics Group Inc. (TMDX) last month performance was -18.69% - The InvestChronicle

Mon, 28 Sep 2020
TransMedics Group (TMDX) Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting - StreetInsider.com

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 27
Shares Float (M) 21
% Held by Insiders 23.26
% Held by Institutions 76.49
Shares Short (K) 1,390
Shares Short P. Month (K) 1,180

Stock Financials

EPS -1.600
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.190
Profit Margin -143.93
Operating Margin -131.55
Return on Assets (ttm) -14.0
Return on Equity (ttm) -37.6
Qtrly Rev. Growth -40.2
Gross Profit (p.s.) 0.510
Sales Per Share 0.890
EBITDA (p.s.) -1.119
Qtrly Earnings Growth
Operating Cash Flow (M) -30
Levered Free Cash Flow (M) -20

Stock Valuations

PE Ratio -8.28
PEG Ratio
Price to Book value 3.16
Price to Sales 14.88
Price to Cash Flow -12.17

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.